Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation

Phase

N/A

Condition

Lymphoma

Bone Marrow Transplant

White Cell Disorders

Treatment

Mindfulness Meditation (MM)

Mindfulness-based Music Therapy (MBMT)

Clinical Study ID

NCT05968963

20230726

1R61CA263335-01A1

Ages > 18
All Genders

Study Summary

The goal of this study is to pilot test an Electronic Health Mindfulness-based Music Therapy Intervention (eMBMT) intervention to improve health-related quality of life (HRQoL) and reduce symptom burden of patients undergoing allogeneic stem cell transplantation (allo-SCT).

Eligibility Criteria

Inclusion

Inclusion Criteria:

≥ 18 years of age
have a primary diagnosis of myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or non Hodgkin's Lymphoma (NHL)
have a treatment plan for an allogeneic hematopoietic stem cell transplant
Speak English or Spanish

Exclusion

Exclusion Criteria:

history of severe psychiatric illness (e.g., psychosis, active suicidality,inpatient treatment in the past 12 months)
severe cognitive impairment (per the short portable mental status questionnaire)
hearing impairment
active alcohol or substance dependence within the past six months
participated in music therapy or mindfulness programs in the past six months

Study Design